Systems epidemiology in cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 11, 2008, Pages 2954-2957

  Lund, Eiliv ^a   Dumeaux, Vanessa ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CARCINOGENESIS; DNA DETERMINATION; ENVIRONMENTAL FACTOR; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEDICAL INFORMATICS; METHODOLOGY; NOTE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EPIDEMIOLOGIC RESEARCH DESIGN; EPIDEMIOLOGY, MOLECULAR; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 55849116361     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0519     Document Type: Note

References (35)

1. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
2. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304-51.
3. Oppenheimer GM. Becoming the Framingham study 1947-1950. Am J Public Health 2005;95:602-10.
4. Lund E, Dumeaux V, Braaten T, et al. Cohort profile: The Norwegian Women and Cancer study-NOWAC-Kvinner og kreft. Int J Epidemiol 2008;37:36-41.
5. Dumeaux V, Børresen-Dale AL, Frantzen JO, et al. Gene expression analyses in breast cancer epidemiology - the Norwegian Women and Cancer postgenome cohort study. Breast Cancer Res 2008;10:R13.
6. Institute of Systems and Synthetic Biology, Imperial College London. www3.imperial.ac.uk/systemsbiology.
7. Green LW. Public health asks of systems science: To advance our evidence-based practice, can you help us get more practice-based evidence? Am J Public Health 2006;96:406-9.
8. Bingham S, Riboli E. Diet and cancer - the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 2004;4:206-15.
9. Grimes DA, Schultz KF. Cohort studies - marching towards outcomes. Lancet 2002;359:341-5.
10. Potter JD. Epidemiology informing clinical practice; from bills of mortality to population laboratories. Nat Clin Pract Oncol 2005;2:625-34.
11. Ransohoff DF. Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 2005;5:142-9.
12. Ebrahim S, Davey Smith G. Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet 2008;123:15-33.
13. Ulrich C, Nijhout HF, Reed MC. Mathematical modelling: epidemiology meets systems biology. Cancer Epidemiol Biomarkers Prev 2006;15:827-9.
14. Ntzani EE, Ioannidis JP. Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet 2003;362:1439-44.
15. Forrest MS, Lan Q, Hubbard AE, et al. Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ Health Perspect 2005;113:801-7.
16. Wang Z, Neuburg D, Li C, et al. Global gene expression profiling in whole-blood samples from individuals exposed to metal fumes. Environ Health Perspect 2005;113:233-41.
17. Terasaka S, Aita Y, Inoue A, et al. Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environ Health Perspect 2004;112:773-81.
18. Lampe JW, Stepaniantes SB, Mao M, et al. Signature of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol Biomarkers Prev 2004;13:445-53.
19. Emilson V, Thorleifsson G, Zhang B, et al. Genetics of gene expression and its effect on disease. Nature 2008;452:423-8.
20. International Agency for Research on Cancer. http:/www.iarc.fr.
21. Dumeaux V, Johansen J, Børresen-Dale AL, Lund E. Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy. Mol Cancer Ther 2006;5:868-76.
22. Dumeaux V, Lund E, Børresen-Dale AL. Comparison of globin RNA processing methods for genome-wide transcriptome analysis from whole-blood. Biomark Med 2008;2:11-21.
23. Grosshans H, Filipowics W. The expanding world of small RNAs. Nature 2008;451:414-6.
24. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-8.
25. Hornsby C, Page KM, Tomlinson IPM. What can we learn from the population incidence of cancer? Armitage and Doll revisited. Lancet Oncol 2007;8:1030-8.
26. Guarnieri DJ, Dileone RJ. MicroRNAs: A new class of gene regulators. Ann Med 2008;40:197-208.
27. Hill AB. The environment and disease: Association or causation? Proc R Soc Med 1965;58:295-300.
28. Ioannides JPA, Bofetta P, Little J, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 2008;37:120-32.
29. Lagiou P, Adami HO, Trichopoulos D. Causality in cancer epidemiology. Eur J Epidemiol 2005;20:565-74.
30. Brustad M, Sandanger T, Nieboer E, Lund E. The 10th anniversary review: when healthy food becomes polluted - implications for public health and dietary advices. J Environ Monit 2008;10:422-7.
31. Vineis P, Perera F. Review: molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old. Cancer Epidemiol Biomarkers Prev 2007;16:1954-65.
32. Croce CM. Oncogenes and cancer. N Eng J Med 2008;358:502-11.
33. Shields PG. Publication bias is a scientific problem with adverse ethical outcomes: the case for a section for null results. Cancer Epidemiol Biomarkers Prev 2000;9:771-2.
34. Haiman CA, Dossus L, Setiawan VW, et al. Genetic variation at the CYP19A1 locus predicting circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res 2007;67:1-5.
35. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452:633-7.